Literature DB >> 28232415

Clinical relevance of pulmonary amyloidosis: an analysis of 76 autopsy-derived cases.

Kamonpun Ussavarungsi1, Eunhee S Yi2, Joseph J Maleszewski2, Paul J Kurtin3, Surenda Dasari4, Jason D Theis3, Angela Dispenzieri5, Jay H Ryu6.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28232415     DOI： 10.1183/13993003.02313-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management.

Authors:  Julius-Valentin Baumgart; Christiane Stuhlmann-Laeisz; Ute Hegenbart; Johanna Nattenmüller; Stefan Schönland; Sandra Krüger; Hans-Michael Behrens; Christoph Röcken
Journal:  Virchows Arch       Date:  2018-08-22       Impact factor: 4.064

2.  Amyloidosis of the respiratory system: 16 patients with amyloidosis initially diagnosed ante mortem by pulmonologists.

Authors:  Masami Yamada; Noboru Takayanagi; Hideaki Yamakawa; Takashi Ishiguro; Tomohisa Baba; Yoshihiko Shimizu; Koji Okudela; Tamiko Takemura; Takashi Ogura
Journal:  ERJ Open Res       Date:  2020-07-27

3.  ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.

Authors:  Thomas H Brannagan; Michaela Auer-Grumbach; John L Berk; Chiara Briani; Vera Bril; Teresa Coelho; Thibaud Damy; Angela Dispenzieri; Brian M Drachman; Nowell Fine; Hanna K Gaggin; Morie Gertz; Julian D Gillmore; Esther Gonzalez; Mazen Hanna; David R Hurwitz; Sami L Khella; Mathew S Maurer; Jose Nativi-Nicolau; Kemi Olugemo; Luis F Quintana; Andrew M Rosen; Hartmut H Schmidt; Jacqueline Shehata; Marcia Waddington-Cruz; Carol Whelan; Frederick L Ruberg
Journal:  Orphanet J Rare Dis       Date:  2021-05-06       Impact factor: 4.123

4.  Pulmonary amyloidosis complicated with pulmonary hemosiderosis, diagnosed with bronchoscopy.

Authors:  Naruhiko Ogo; Toyoshi Yanagihara; Ryota Nishimura; Hiroshi Mannoji; Reiko Yoneda; Masayasu Hayashi; Ayaka Egashira; Tatsuma Asoh; Takashige Maeyama
Journal:  Respir Med Case Rep       Date:  2021-03-19

5.  Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia.

Authors:  Indranee Rajapreyar; Joanna Joly; Jose Tallaj; Salpy V Pamboukian; Ayman Haj Assad; Carrie Lenneman; Silvio Litovsky; Arka Chatterjee; Charles Hoopes; Andrew Lenneman
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-11-20

6.  Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients.

Authors:  Astrid Monfort; Alexia Rivas; Rishika Banydeen; Jocelyn Inamo; Karim Farid; Remi Neviere
Journal:  Respir Res       Date:  2022-03-27

7.  Frequency and Significance of Pathologic Pulmonary Findings in Postmortem Examinations-A Single Center Experience before COVID-19.

Authors:  Sabina Berezowska; Andreas Schmid; Tereza Losmanová; Mafalda Trippel; Annika Blank; Yara Banz; Stephan M Jakob; Rupert Langer
Journal:  Diagnostics (Basel)       Date:  2021-05-18

8.  Diffuse parenchymal pulmonary amyloidosis associated with multiple myeloma: a case report and systematic review of the literature.

Authors:  Yin Liu; Zhibin Jin; Haiyan Zhang; Yingwei Zhang; Minke Shi; Fanqing Meng; Qi Sun; Hourong Cai
Journal:  BMC Cancer       Date:  2018-08-08       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.